FIELD: applied microbiology. SUBSTANCE: vaccinal strain A/47/Peking/95/35 (H1N1), which is reassortant, is obtained by cross-breeding of epidemic virus A/Peking/262/95 (H1N1) with cold-adapted temperature-sensitive virus A/Leningrad/134/47/57 (H2N2), which is attenuation donor. The strain is harmless for babies. It actively multiplies in developing chicken embryos at optimal temperature 33-34 C and is characterized by temperature sensitivity and cold adaptability. Reassortant inherits two genes from epidemic virus, which encode surface proteins (gemmagglutinin and neuraminidase), and six genes from attenuation donor encoding non-glycosylated proteins. In addition, the strain does non induce immune response in babies during intranasal injection. EFFECT: reliably enabled isolation of reassorted vaccinal strains from newly appearing epidemic viruses. 1 tbl
Authors
Dates
2000-11-27—Published
1999-05-25—Filed